Invesco Ltd. Neoleukin Therapeutics, Inc. Transaction History

Invesco Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.92 - $2.25 $10,338 - $25,285	-11,238 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.72 - $5.23 $149 - $455	87 Added 0.78%	11,238 $21,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.75 $21,817 - $36,363	-4,692 Reduced 29.62%	11,151 $53,000
Q3 2021 Nov 15, 2021	BUY	$6.05 - $9.66 $10,720 - $17,117	1,772 Added 12.59%	15,843 $115,000
Q2 2021 Aug 17, 2021	BUY	$9.23 - $13.12 $129,875 - $184,611	14,071 New	14,071 $130,000
Q3 2020 Nov 16, 2020	SELL	$9.68 - $17.01 $232,368 - $408,325	-24,005 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.95 - $17.05 $21,442 - $36,742	2,155 Added 9.86%	24,005 $399,000
Q1 2020 May 15, 2020	BUY	$6.12 - $13.64 $133,722 - $298,034	21,850 New	21,850 $249,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.